Prostate Cancer
Showing NaN - NaN of 117
Architectural Heterogeneity in Prostate Cancer UsingFine Needle
Not yet recruiting
- Prostate Cancer
- Fine Needle Photoacoustic Probe
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jul 19, 2023
Prostate Cancer Trial in Ann Arbor (web-based tool (MAP- Management of Active surveillance in Prostate Cancer), MUSIC website)
Recruiting
- Prostate Cancer
- web-based tool (MAP- Management of Active surveillance in Prostate Cancer)
- MUSIC website
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Feb 28, 2023
Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)
Recruiting
- Prostate Cancer
- Docetaxel 75 mg/m2
- +2 more
-
Gilbert, Arizona
- +52 more
Feb 2, 2023
Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))
Active, not recruiting
- Prostate Cancer
- ARN-509 (Phase 1)
- ARN-509 (Phase 2)
-
San Diego, California
- +14 more
Jan 17, 2023
Prostate Cancer Trial in Canada, United States (70.2 Gy 3D-CRT/IMRT, 79.2 Gy 3D-CRT/IMRT)
Completed
- Prostate Cancer
- 70.2 Gy 3D-CRT/IMRT
- 79.2 Gy 3D-CRT/IMRT
-
Long Beach, California
- +85 more
Dec 27, 2022
EDRN Prostate MRI Biomarker Study
Recruiting
- PSA
- Prostate Cancer
- MRI prostate
-
Ann Arbor, MichiganUniversity of Michigan
Jan 4, 2023
Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)
Recruiting
- Small Cell Lung Cancer
- +8 more
- ladiratuzumab vedotin
- pembrolizumab
-
Chandler, Arizona
- +65 more
Dec 19, 2022
Prostate Cancer Trial in United States (TAK-700, Bicalutamide)
Active, not recruiting
- Prostate Cancer
-
Birmingham, Alabama
- +559 more
Dec 5, 2022
Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)
Active, not recruiting
- Prostate Cancer
- abiraterone acetate
- Prednisone
-
Jonesboro, Arkansas
- +204 more
Nov 30, 2022
Insomnia, Breast Cancer, Prostate Cancer Trial in Ann Arbor (Sleep Coach App)
Completed
- Insomnia
- +3 more
- Sleep Coach App
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Nov 1, 2022
Prostate Cancer Trial in Ann Arbor (Mindfulness-based Intervention, Usual Care)
Terminated
- Prostate Cancer
- Mindfulness-based Intervention
- Usual Care
-
Ann Arbor, MichiganUniversity of Rogel Cancer Center
Oct 6, 2022
Breast Cancer, Prostate Cancer, Hematologic Malignancy Trial in Ann Arbor (Wearable Sensor, Blue-blocking glasses, Clear
Recruiting
- Breast Cancer
- +4 more
- Wearable Sensor
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Sep 20, 2022
Prostate Cancer Trial in United States (Decipher Prostate Cancer Classifier)
Active, not recruiting
- Prostate Cancer
- Decipher Prostate Cancer Classifier
-
Ann Arbor, Michigan
- +12 more
Aug 26, 2022
Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)
Prostate Cancer Trial in Worldwide (Standard of Care)
Recruiting
- Prostate Cancer
- Standard of Care
-
Birmingham, Alabama
- +107 more
Aug 17, 2022
Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)
Recruiting
- Prostate Cancer
- +4 more
- PET-directed Local Therapy using Surgery
- +10 more
-
Long Beach, California
- +15 more
Jul 29, 2022
Prostate Cancer, Bone Metastases, Prostate Tumors Trial in United States (LHRH agonist/antagonist, Bicalutamide, Radium-223
Terminated
- Prostate Cancer
- +2 more
- LHRH agonist/antagonist
- +2 more
-
Phoenix, Arizona
- +11 more
Jul 7, 2022
Prostate Cancer Trial in United States (Prolaris Testing)
Terminated
- Prostate Cancer
- Prolaris Testing
-
Homewood, Alabama
- +33 more
Jun 17, 2022
Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- SRF617
- +2 more
-
Miami, Florida
- +6 more
Jun 13, 2022